CAPS Rating: 2 out of 5

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.


Player Avatar penywise (70.54) Submitted: 5/28/2011 10:16:05 AM : Outperform Start Price: $2.50 AOBID Score: -38.93

Down so long that it looks like up to me. Don't get me wrong - I don't think there is a great long term investment thesis on this one, but at some point the ugliness in the Chinese small cap market has to stop - and when it does, a profitable small company with a clean balance sheet should be worth something. If this stock goes up 10 cents it will beat the market over the next year in terms of a percentage move.

Member Avatar jonboy13 (20.67) Submitted: 7/17/2011 11:23:36 AM
Recs: 0

I have felt just that way for awhile myself. If one looks at the change from 50 day m/a on most of these China companies now (7/17), I believe the naysayers might be very surprised. I'm re-adding it today. Not ALL the Chinese are crooked. As a matter of fact, I'd prefer to bet on the avg. China businessman for honesty than his American counterpart.

Featured Broker Partners